Clinical and Translational Science Awards (CTSA) Program

Coordination, Communication, and Operations Support (CCOS)

Connecting translational science teams nationwide!

Explore Hubs (69)Find Members (2000+)

About Us

Powering the CTSA

About CCOS

CTSA Program

ncats.nih.gov

CCOS contributes to bringing the National Center for Advancing Translational Sciences (NCATS) CTSA Program together as one network. When the consortium moves in sync, ideas travel farther and patients benefit faster.

Across hubs, we align people, data, and day-to-day operations. We coordinate groups and meetings, communicate program updates and CTSA impact clearly, and streamline logistics. Program data turns into insights, and shared tools and training help teams act with confidence.

Calendar

Upcoming Events

View Calendar

Groups and Meetings

Ready to Collaborate?

Find Groups and Meetings

Steering Committee

Leaders guiding policy and collaboration across the CTSA Program.

Consortium Groups

Experts in translational fields sharing strategies with peers and NCATS.

Enterprise Committees

Cross hub teams driving translational science forward through collaborative, project-based work.

Working Groups

Teams from multiple CTSA hubs addressing key clinical and translational science gaps.

Impact

From research to real world results

See how CTSA-supported work is translating evidence into health, care, and community-health improvements.

Explore Impact

19

Impact Stories

Helping Babies Suffering from Opioid Withdrawal at Birth

Abstract

From the 1990s to today, a growing number of babies are exposed to an opioid before birth and have withdrawal soon after, a condition called neonatal abstinence syndrome. They have painful symptoms and may need to be in the hospital for weeks. Before 2017, there was no research on which medicines best calm these babies. When Dr. Jonathan Davis and his team set out to change that, Tufts Clinical and Translational Science Institute (CTSI) helped by designing a clinical trial and analyzing data from many hospitals. Results showed that a different medicine (methadone)--not the one used most often (morphine)--led to fewer days of treatment and shorter hospital stays. This became part of the American Academy of Pediatrics treatment guidelines. Tufts CTSI also assisted Dr. Davis as he worked to change research rules and laws to solve barriers to doing the study. This led Dr. Davis to take part in developing best practices for including newborns in health research that guide today’s studies.

Posted Apr 21, 2026

Read Full Story

News